Cbd Life Sciences Inc
CBD Life Sciences Inc. engages in the development and marketing a line of cannabidiol based organic products. Its cannabidiol based organic products include hemp drops, massage oils, recovery pain relief creams, anxiety and sleep solutions supplements, edibles, coffee, wine, skincare line, tablets, and a line of pet products. CBD Life Sciences Inc. formerly known as Optium Cyber Systems, Inc. and… Read more
Cbd Life Sciences Inc (CBDL) - Total Liabilities
Latest total liabilities as of March 2025: $80.70K USD
Based on the latest financial reports, Cbd Life Sciences Inc (CBDL) has total liabilities worth $80.70K USD as of March 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Cbd Life Sciences Inc - Total Liabilities Trend (2011–2024)
This chart illustrates how Cbd Life Sciences Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Cbd Life Sciences Inc Competitors by Total Liabilities
The table below lists competitors of Cbd Life Sciences Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Together Startup Network Ltd
TA:TGTR
|
Israel | ILA56.03 Million |
|
AngioSoma Inc
PINK:GSTC
|
USA | $1.71 Million |
|
J M AB
BE:JMM
|
Germany | €21.56 Billion |
|
ATEA (MKL.SG)
STU:MKL
|
Germany | €12.01 Billion |
|
Global Hemp Group Inc
PINK:GBHPF
|
USA | $6.13 Million |
Liability Composition Analysis (2011–2024)
This chart breaks down Cbd Life Sciences Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.60 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.19 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.16 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Cbd Life Sciences Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Cbd Life Sciences Inc (2011–2024)
The table below shows the annual total liabilities of Cbd Life Sciences Inc from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $14.13K | -42.88% |
| 2023-12-31 | $24.74K | -85.39% |
| 2022-12-31 | $169.33K | +457.11% |
| 2021-12-31 | $30.39K | -81.48% |
| 2020-12-31 | $164.10K | -64.35% |
| 2019-12-31 | $460.35K | +127.87% |
| 2018-12-31 | $202.02K | -31.19% |
| 2017-12-31 | $293.60K | -54.51% |
| 2014-12-31 | $645.45K | +11.18% |
| 2013-12-31 | $580.52K | +2010.98% |
| 2012-12-31 | $27.50K | -184.79% |
| 2011-12-31 | $-32.43K | -- |